US Patent Issued to SUN PHARMACEUTICAL INDUSTRIES on Jan. 27 for "Parenteral unit dosage form of dihydroergotamine" (Indian Inventors)

ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,533,351, issued on Jan. 27, was assigned to SUN PHARMACEUTICAL INDUSTRIES Ltd. (Mumbai, India).

"Parenteral unit dosage form of dihydroergotamine" was invented by Alpesh Goyani (Baroda, India), Deepak Singodia (Baroda, India), Bhaskar Pallerla (Baroda, India), Sudeep Kumar Agrawal (Baroda, India), Subhas Balaram Bhowmick (Baroda, India) and Rajamannar Thennati (Baroda, India).

According to the abstract* released by the U.S. Patent & Trademark Office: "A parenteral unit dosage form comprising an aqueous solution of dihydroergotamine or pharmaceutically acceptable salt thereof as a sole active ingredient, one or more pH adjusting agents, and optionally one or more co-solvents, wherein ...